Plasma Homocysteine and Risk for Congestive Heart Failure in Adults Without Prior Myocardial Infarction
Open Access
- 12 March 2003
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 289 (10) , 1251-1257
- https://doi.org/10.1001/jama.289.10.1251
Abstract
Congestive heart failure (CHF) is a public health problem with considerable morbidity, mortality, and economic burden.1,2 Thus, identification of risk factors for CHF is a public health priority. Several epidemiological investigations have identified advancing age, myocardial infarction (MI), hypertension, valve disease, diabetes mellitus, and obesity as key risk factors for CHF.3-6Keywords
This publication has 34 references indexed in Scilit:
- Obesity and the Risk of Heart FailureNew England Journal of Medicine, 2002
- Hyperhomocysteinemia Evoked by Folate DepletionArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjectsMetabolism, 2001
- Heart failure in the general population of men - morbidity, risk factors and prognosisJournal of Internal Medicine, 2001
- The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine ConcentrationsNew England Journal of Medicine, 1999
- Incidence and aetiology of heart failure; a population-based studyEuropean Heart Journal, 1999
- Homocysteine and AtherothrombosisNew England Journal of Medicine, 1998
- HOMOCYSTEINE AND VASCULAR DYSFUNCTIONLife Sciences, 1997
- The oxidant stress of hyperhomocyst(e)inemia.Journal of Clinical Investigation, 1996
- Epidemiological Approaches to Heart Disease: The Framingham StudyAmerican Journal of Public Health and the Nations Health, 1951